MSDC 0160 (Synonyms: 米格列酮; Mitoglitazone; CAY10415)
目录号: PL01090 纯度: ≥98%
CAS No. :146062-49-9
商品编号 规格 价格 会员价 是否有货 数量
PL01090-2mg 2mg ¥655.27 请登录
PL01090-10mg 10mg ¥1978.18 请登录
PL01090-50mg 50mg ¥6181.82 请登录
PL01090-100mg 100mg ¥8654.55 请登录
PL01090-200mg 200mg 询价 询价
PL01090-500mg 500mg 询价 询价
PL01090-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1360.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
MSDC 0160
中文别名
CAY10415 抑制剂;匹格列酮;酸雾抑制剂
英文名称
MSDC 0160
英文别名
Mitoglitazone;5-(4-(2-(5-Ethylpyridin-2-yl)-2-oxoethoxy)-benzyl)thiazolidine-2,4-dione;CAY10415;MSDC-0160;CAY-10415;MSDC0160;5-[[4-[2-(5-ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-2,4-Thiazolidinedione;MSDC-0160(CAY10415);CAY10415 (Mitoglitazone);2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-;CAY 10415;MSDC 0160;5-(4-(2-(5-ethylpyridin-2-yl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione;US9562012, mitoglitazone;Mitoglitazone, >=98% (HPLC);IRNJSRAGRIZIHD-UHFFFAOYSA-N;BDBM228129;BCP16099;s7453;2;MDHB
Cas No.
146062-49-9
分子式
C19H18N2O4S
分子量
370.42
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
MSDC 0160 (Mitoglitazone) 是调节噻唑烷二酮的线粒体靶标 (mTOT) 的胰岛素增敏剂,也是线粒体丙酮酸载体 (MPC) 的调节剂。MSDC 0160 是一种噻唑烷二酮 (TZD),具有抗糖尿病和神经保护活性作用。MSDC 0160 具有用于阿尔茨海默氏病的潜力。
生物活性
MSDC 0160 (Mitoglitazone) is a mitochondrial target of thiazolidinediones (mTOT)-modulating insulin sensitizer and a modulator of mitochondrial pyruvate carrier (MPC). MSDC 0160 is a thiazolidinedione (TZD) with antidiabetic and neuroprotective activities. MSDC 0160 has the potential for Alzheimer′s disease.
性状
Solid
体外研究(In Vitro)
MSDC 0160 (Mitoglitazone; 1-50 μM; for 24 hours) significantly decreases phosphorylation of mTOR at 20 and 50 μM.
MSDC 0160 acts as insulin sensitizers without activating PPARγ.
MSDC 0160 (10 μM; pretreatment 1 hour) prevents the MPP (10 μM)-induced loss of both tyrosine hydroxylase (TH)-immunoreactive differentiated Lund human mesencephalic (LUHMES) cells.
MSDC 0160 (10 or 100 μM) prevents the loss of GFP-fluorescent dopaminergic neurons induced by MPP (0.75 mM) in nematodes.
MSDC 0160 (10-20 μM) in conbination with IGF-1 prevents the loss of insulin content and maintains insulin secretion.
MSDC 0160 (1-50 μM) treatment maintains human β-cell phenotype. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
MSDC 0160 (Mitoglitazone; 30 mg/kg; oral gavage; daily; for 7 days) improves locomotor behavior, increases survival of nigral dopaminergic neurons, boosts striatal dopamine levels, and reduces neuroinflammation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
ClinicalTrial
参考文献
[1]. Rohatgi N, et al. Novel insulin sensitizer modulates nutrient sensing pathways and maintains β-cell phenotype in human islets. PLoS One. 2013 May 1;8(5):e62012.
[2]. Ghosh A, et al. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration inexperimental models of Parkinsons disease. Sci Transl Med. 2016 Dec 7;8(368):368ra174.
溶解度数据
In Vitro: DMSO : 33.33 mg/mL (89.98 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2